Marker Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Marker Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • Marker Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $232K, a 26.6% decline year-over-year.
  • Marker Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $1.11M, a 2.69% increase from 2021.
  • Marker Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.08M, a 98% increase from 2020.
  • Marker Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $544K, a 142% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $232K -$84K -26.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $316K +$78K +32.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $238K +$181K +318% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $57K +$1K +1.79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q2 2019 $111K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $56K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.